A new experimental drug is showing promising potential in the treatment of pancreatic cancer, offering hope for improved outcomes through precision medicine. In this recent News4Jax segment, experts discuss how KRAS-targeting therapies could change the future of pancreatic cancer care and potentially extend survival for patients with advanced disease.
Watch the full video to learn more about this emerging breakthrough in cancer treatment.
